Company Filing History:
9 out of 1,310 
2 out of 2 
2 out of 560 
Years Active: 2015-2024
Title: Annette Khaled: Innovator in Cancer Treatment and Drug Delivery
Introduction
Annette Khaled is a prominent inventor based in Orlando, FL, known for her significant contributions to the fields of cancer treatment and drug delivery. With a total of 9 patents to her name, she has made remarkable strides in developing innovative methods and compositions that address critical health challenges.
Latest Patents
Among her latest patents is a groundbreaking method and compositions comprising a CT20 peptide. This invention focuses on using the CT20 peptide to treat cancers that express chaperonin containing TCP (CCT). Another notable patent involves theranostic nanoparticles designed for drug delivery. This nanoparticle features a hyperbranched polyester (HBPE) with a hydrophobic interior, polyglutamate folate ligands conjugated to it, and one or more PET detectable isotopes, along with methods for their application.
Career Highlights
Throughout her career, Annette has worked with esteemed organizations such as the University of Central Florida Research Foundation, Inc. and Sanford Burnham Prebys Medical Discovery Institute at Lake Nona. Her work in these institutions has been pivotal in advancing research and development in her areas of expertise.
Collaborations
Annette has collaborated with notable colleagues, including Rebecca Boohaker and Michael Lee, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Annette Khaled's work exemplifies the impact of innovative thinking in the medical field. Her patents and collaborations highlight her commitment to improving cancer treatment and drug delivery systems.